Summit Investment Advisors Inc. Boosts Stock Holdings in Integer Holdings Co. (NYSE:ITGR)

Summit Investment Advisors Inc. lifted its stake in Integer Holdings Co. (NYSE:ITGR) by 5.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,488 shares of the medical equipment provider’s stock after buying an additional 175 shares during the period. Summit Investment Advisors Inc.’s holdings in Integer were worth $462,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Loomis Sayles & Co. L P increased its stake in Integer by 3.8% in the 4th quarter. Loomis Sayles & Co. L P now owns 558,715 shares of the medical equipment provider’s stock worth $74,041,000 after purchasing an additional 20,688 shares during the period. Congress Asset Management Co. increased its stake in shares of Integer by 2.0% in the fourth quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider’s stock worth $66,041,000 after buying an additional 9,565 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Integer by 1.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 408,588 shares of the medical equipment provider’s stock valued at $54,146,000 after buying an additional 4,559 shares during the last quarter. Lord Abbett & CO. LLC boosted its position in Integer by 3.5% during the 3rd quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider’s stock valued at $37,716,000 after buying an additional 9,754 shares during the period. Finally, Tributary Capital Management LLC grew its holdings in Integer by 0.8% in the 4th quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider’s stock worth $38,103,000 after acquiring an additional 2,289 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently weighed in on ITGR. KeyCorp increased their target price on shares of Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Truist Financial cut their price objective on Integer from $163.00 to $140.00 and set a “buy” rating on the stock in a research report on Friday, April 11th. Oppenheimer downgraded Integer from an “outperform” rating to a “market perform” rating in a report on Friday, February 21st. Benchmark lifted their price target on shares of Integer from $140.00 to $150.00 and gave the company a “buy” rating in a report on Friday, February 21st. Finally, Raymond James began coverage on shares of Integer in a report on Friday, March 28th. They issued an “outperform” rating and a $145.00 price objective for the company. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $146.00.

Integer Stock Performance

Shares of ITGR stock opened at $116.99 on Friday. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62. The company’s fifty day moving average price is $121.57 and its 200-day moving average price is $130.56. The stock has a market cap of $4.08 billion, a PE ratio of 34.82, a price-to-earnings-growth ratio of 1.72 and a beta of 1.09. Integer Holdings Co. has a 12 month low of $104.93 and a 12 month high of $146.36.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The business had revenue of $449.50 million for the quarter, compared to the consensus estimate of $446.28 million. On average, equities analysts expect that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.